3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Withdrawn
1
Unknown
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Rectal Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Advanced Gastric Cancer
1
Interventions
Capecitabine
13
Oxaliplatin
10
Radiotherapy
8
Surgical Procedures, Operative
6
Drug Therapy
5
tislelizumab
4
Irinotecan
4
sintilimab
3
Neoadjuvant Therapy
3
Immunotherapy
3
Fluorouracil
3
Endoscopic Mucosal Resection
3
Bevacizumab
3
spartalizumab
2
raltitrexed
2
XELOX
2
Trinitrotoluene
2
Radiation
2
Immune Checkpoint Inhibitors
2
Folfox protocol
2
Cetuximab
2
toripalimab
1
sperm releasing substance
1
saxagliptin
1
s-formylglutathione hydrolase
1
envafolimab
1
disitamab vedotin
1
cemiplimab
1
camrelizumab
1
balstilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Rectal Neoplasms
×
Trifluridine
×
Clear all
NCT06872606
2025-03-12
SCRIPBOT
Sir Run Run Shaw Hospital
Phase 2
Not yet recruiting
33 enrolled